101 related articles for article (PubMed ID: 8599870)
41. A comparison of clonogenic, microtetrazolium and sulforhodamine B assays for determination of cisplatin cytotoxicity in human ovarian carcinoma cell lines.
Perez RP; Godwin AK; Handel LM; Hamilton TC
Eur J Cancer; 1993; 29A(3):395-9. PubMed ID: 8398340
[TBL] [Abstract][Full Text] [Related]
42. Effect of ERCC-1 overexpression on sensitivity of Chinese hamster ovary cells to DNA damaging agents.
Bramson J; Panasci LC
Cancer Res; 1993 Jul; 53(14):3237-40. PubMed ID: 8324733
[TBL] [Abstract][Full Text] [Related]
43. The role of apoptosis in cell killing by cisplatin: a flow cytometric study.
Ormerod MG; Orr RM; Peacock JH
Br J Cancer; 1994 Jan; 69(1):93-100. PubMed ID: 8286217
[TBL] [Abstract][Full Text] [Related]
44. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation.
Oberhammer F; Wilson JW; Dive C; Morris ID; Hickman JA; Wakeling AE; Walker PR; Sikorska M
EMBO J; 1993 Sep; 12(9):3679-84. PubMed ID: 8253089
[TBL] [Abstract][Full Text] [Related]
45. Cisplatin induces apoptosis in a human ovarian carcinoma cell line without concomitant internucleosomal degradation of DNA.
Ormerod MG; O'Neill CF; Robertson D; Harrap KR
Exp Cell Res; 1994 Apr; 211(2):231-7. PubMed ID: 8143768
[TBL] [Abstract][Full Text] [Related]
46. Differential sensitivity to the induction of apoptosis by cisplatin in proliferating and quiescent immature rat thymocytes is independent of the levels of drug accumulation and DNA adduct formation.
Evans DL; Tilby M; Dive C
Cancer Res; 1994 Mar; 54(6):1596-603. PubMed ID: 8137265
[TBL] [Abstract][Full Text] [Related]
47. Multiple cell cycle access to the apoptotic death programme in human neuroblastoma cells.
Piacentini M; Fesus L; Melino G
FEBS Lett; 1993 Apr; 320(2):150-4. PubMed ID: 8096193
[TBL] [Abstract][Full Text] [Related]
48. Rapid gene-specific repair of cisplatin lesions at the human DUG/DHFR locus comprising the divergent upstream gene and dihydrofolate reductase gene during early G1 phase of the cell cycle assayed by using the exonucleolytic activity of T4 DNA polymerase.
Rampino NJ; Bohr VA
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):10977-81. PubMed ID: 7971995
[TBL] [Abstract][Full Text] [Related]
49. Dexamethasone and etoposide induce apoptosis in rat thymocytes from different phases of the cell cycle.
Fearnhead HO; Chwalinski M; Snowden RT; Ormerod MG; Cohen GM
Biochem Pharmacol; 1994 Sep; 48(6):1073-9. PubMed ID: 7945400
[TBL] [Abstract][Full Text] [Related]
50. Differential formation and enhanced removal of specific cisplatin-DNA adducts in two cisplatin-selected resistant human testicular teratoma sublines.
Hill BT; Shellard SA; Fichtinger-Schepman AM; Schmoll HJ; Harstrick A
Anticancer Drugs; 1994 Jun; 5(3):321-8. PubMed ID: 7919457
[TBL] [Abstract][Full Text] [Related]
51. DNA damage tolerance, mismatch repair and genome instability.
Karran P; Bignami M
Bioessays; 1994 Nov; 16(11):833-9. PubMed ID: 7840761
[TBL] [Abstract][Full Text] [Related]
52. Cell death: the significance of apoptosis.
Wyllie AH; Kerr JF; Currie AR
Int Rev Cytol; 1980; 68():251-306. PubMed ID: 7014501
[No Abstract] [Full Text] [Related]
53. cis-Pt(NH3)2Cl2 and trans-Pt(NH3)2Cl2 inhibit DNA synthesis in cultured L1210 leukemia cells.
Salles B; Butour JL; Lesca C; Macquet JP
Biochem Biophys Res Commun; 1983 Apr; 112(2):555-63. PubMed ID: 6682656
[TBL] [Abstract][Full Text] [Related]
54. Epidermal growth factor and tumor promoters prevent DNA fragmentation by different mechanisms.
Kanter P; Leister KJ; Tomei LD; Wenner PA; Wenner CE
Biochem Biophys Res Commun; 1984 Jan; 118(2):392-9. PubMed ID: 6608349
[TBL] [Abstract][Full Text] [Related]
55. Drugs five years later. Cisplatin.
Loehrer PJ; Einhorn LH
Ann Intern Med; 1984 May; 100(5):704-13. PubMed ID: 6370067
[TBL] [Abstract][Full Text] [Related]
56. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation.
Wyllie AH
Nature; 1980 Apr; 284(5756):555-6. PubMed ID: 6245367
[TBL] [Abstract][Full Text] [Related]
57. Multiple mechanisms of resistance to cis-diamminedichloroplatinum(II) in murine leukemia L1210 cells.
Richon VM; Schulte N; Eastman A
Cancer Res; 1987 Apr; 47(8):2056-61. PubMed ID: 3828995
[TBL] [Abstract][Full Text] [Related]
58. Glutathione depletion reverses cisplatin resistance in murine L1210 leukemia cells.
Hromas RA; Andrews PA; Murphy MP; Burns CP
Cancer Lett; 1987 Jan; 34(1):9-13. PubMed ID: 3802072
[TBL] [Abstract][Full Text] [Related]
59. Improved program for the analysis of DNA histograms.
Ormerod MG; Payne AW; Watson JV
Cytometry; 1987 Nov; 8(6):637-41. PubMed ID: 3428045
[TBL] [Abstract][Full Text] [Related]
60. Influence of cis-diamminedichloroplatinum(II) on DNA synthesis and cell cycle progression in excision repair proficient and deficient Chinese hamster ovary cells.
Sorenson CM; Eastman A
Cancer Res; 1988 Dec; 48(23):6703-7. PubMed ID: 3180081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
